Call for Application 2022 Opening soon!
Next Roadshow November 17th
Program Duration 9 months
Data-driven, personalized, high-risk pregnancy care through an app promoting lifestyle changes. Adira health empowers pregnant women diagnosed with high blood pressure, gestational hypertension, and pre-eclampsia to gain awareness of their condition, signs, and symptoms improving birth experience and healthspan. Our health data and wellbeing counseling combined with care coordination enables better pregnancy outcomes for mom and baby.
Tech4Eva and the entire team was eagerly on the look-out for opportunities helpful to Adira Health and the entire cohort. The fine-tuned program and mentoring was instrumental in getting us further off the ground. I enjoyed the greater community and network of startups, partners, like-minded and experts in healthcare for women. If you look for a program and a cohort that puts start-ups first – then Tech4Eva is perfect for you!
Beyond Genomix is a clinical stage MedTech developing next generation technologies for ncDNA analysis. With a focus on reproductive health, we have developed the only infertility test, capable of diagnosing every woman including those with an idiopathic condition, from the comfort of their home.
CareMother Baby Beat is a portable, wireless, smartphone based, non-stress test (NST) device with AI capability, that can be used by mothers for self-monitoring of fetal health at home, with results shared with their doctor online for advice.
Egal’s Pads on a Roll help women manage their periods safely, privately, hygienically and with dignity. Pads on a Roll look like toilet paper, are individually wrapped, and are installed next to toilet paper so the products are available when and where they are needed. Typically period pads or tampons, if they are even stocked, are located in separate vending machines by the sink -- not where you want to find them, and often too late to help.
Egal means equal…all bodily functions should be treated equally.
Tech4Eva has been great. The mentors are especially helpful. The cohort is inspiring us, and you really get to know what everyone is going through more than other accelerators I have been involved with. Additionally, the special sessions have super useful specialists that I have learned a lot from. Since we have started Tech4 Eva, we have gotten a lot more global interest.
Hale is a platform providing women with chronic pelvic pain with personalized mental health, to improve their quality of life.
Research confirms that mental health is metabolic health. HEALTHY-LONGER has developed and validated the first neuro-metabolic assessment and neuro-nutritional treatment addressing the root cause of mental health vulnerability and disorders – neuro-nutrient deficiencies. The technology is intended to be the first metabolic neuro-biomarker based diagnostic tool in mental health.
Being in the Tech4Eva program helped in building connections with the FemTech world and Tech4Eva's partners and validate our go-to-market strategy and closing our seed round.
The program also allows us to connect with potential partners, collaborators, distributors, and market access consultants. I'm also looking forward to making connections with global FemTech companies.
Intignus Biotech is developing simple and accessible solutions in the area of maternal and child health care. We aim to better clinical, operational, and economic outcomes by using point-of-care tests that allow on-the-spot decision-making for clinicians. Our first product addresses the unmet need for early screening of preeclampsia. This pregnancy-related disorder can strike quickly, potentially causing severe and immediate complications unless the pregnancy is induced. We have developed an affordable and easy-to-use screening test for all pregnant women which can predict preeclampsia development in the upcoming weeks of gestation.
Tech4Eva creates a microcosm for budding FemHealth start-ups to share and grow in a special and focused community
It provided a great opportunity for peer learning from other founders and I also really valued having a Mentor who has experience building a start-up in SSA, being available to brainstorm some of the challenges of entrepreneurship.
We boost In Vitro Fertilisation success, helping doctors in decision-making by detecting the right timing for embryo transfer. We measure uterine readiness for embryo transfer on the same day of the transfer without interfering with the patient's journey and preserving endometrial tissue integrity.
$2 million fundraised in 2023
Tech4Eva was an eye opener and acted as a true accelerator of our mindset and the overall company evolution process. Monthly updating with a dedicated mentor has been fundamental in our journey. When peers are so close to you in their profile and needs, this is even a much better experience. I have found a community with a drive for cooperation and partnering. We are very grateful to the program and the organizers for the opportunity. We encourage young start-ups in Femtech to apply for the next cohort.
With our AI-driven technologies we increase chances for people to become parents. We provide greater accuracy in the diagnostic and treatment process, reducing the time and cost associated with fertility treatments and leading to better outcomes for our customers. Our flagship solutions are EMBRYOAID for automatic embryo ranking and FOLLISCAN - a 10-second ai-powered follicular ultrasound monitoring. Founder-led and with most PhDs, we have 50 experienced AI specialists.
Seed funding round closed in 2023 with an impressive $2M secured from Tangent Line Ventures and Peleton.
Participating in the Tech4Eva program was a huge support for MIM Fertility. The support and good energy we received during the program from the organizers and other participants were absolutely of great value to us.
LoOoP by Neuraura: Restoring Women’s Reproductive and Metabolic Health with a Wearable Bioelectronic Device. Neuraura is bringing to market the first effective, widely accessible treatment for PCOS as an over-the-counter, affordable device that augments the body's natural processes rather than just masking the symptoms.
Tech4Eva brings together some of the most promising start-ups in women’s health to provide peer support, industry-specific insights and world-class connections to potential customers, partners, and investors. In a few short months, I have built an ecosystem of committed, knowledgeable and accomplished experts in women’s health spanning the globe. I feel completely blessed to have this powerful group of supporters to call upon and ask for support, expertise, and connections. Given the headwinds that still exist in this field, this network is invaluable, and I would encourage anyone entering this industry to invest in that network early to test your ideas and learn from other’s successes and missteps.
NuroKorFemtech is developing new technology that can deploy personalized treatments that meet the needs of each individual and their experience of painful conditions affecting female reproductive health. Our team is bringing together expertise in bioelectronics, data science, and AI/ML to create the world’s first adaptive app-driven technology for menstrual health. We are on a real mission to revolutionize women's healthcare with the smartest therapeutic wearable. Period.
Palpa is a unique product to train breast self-examination in the shower. It is a breast-shaped device that teaches women what an abnormality feels like and how to detect a tumor in their breasts to improve early detection of breast cancer during their shower routine.
I believe that Tech4Eva facilitates access to invaluable advisors and potential clients, allowing founders to gain valuable insights from the consumer sector and draw significant conclusions from those experiences.
Founded in 2004, Predilife, a pioneer of predictive medicine in France, designs and markets predictive tests, giving everyone the chance to find out their own risk of developing serious diseases. It combines proven medical techniques with Artificial Intelligence and Big Data.
Predictive medicine involves anticipating an individual’s future so that action can be taken in time thanks to personalised prevention, either by reducing risk, or by identifying the disease as early as possible. Serious conditions, such as cancer and heart attacks, can now be prevented better.
Partnership with Groupe Mutuel and a $2 million fundraise in 2023
Thanks to the various support services offered by Tech4Eva, our aim is to structure our international offering. The knowledge we have acquired about the various markets, international trade fairs and the quality of the network made available by Tech4Eva will enable us to arrive better prepared and more quickly on our various target market.
Ru Medical is creating innovative technologies to transform menopausal care. Unpause is our holistic digital platform where menopausal women can log and track their symptoms and treatments to understand their journey better. The platform also connects to novel non-invasive technologies to relieve specific symptoms of menopause. Coolzen, our premier smart wearable, provides relief from hot flashes using the body’s natural cooling mechanism to bring instant relief to the user.
The workshops and mentors of Tech4Eva have been invaluable in bringing critical advice in jumping hurdles the start-up world presents. The coaches have been instrumental in connecting us with the right people to help our business grow.
Samphire Neuroscience is a women's health company that builds neurotechnology-based solutions for neglected women's health needs. Its first medical device, the Samphire Hairband, will be available in early 2024 and is a wearable, non-invasive device that can address premenstrual low mood, anxiety, and menstrual pain complaints in women of reproductive age with diagnoses of PMS, PMDD, and dysmenorrhea from a home setting, drastically improving the standard of care and reducing the time to treatment for most women with these conditions
We are excited about the opportunity to collaborate with Tech4Eva's brilliant mentors and to learn from peers about creating effective solutions for women in the 21st century. In particular, we hope to gain early exposure to diverse distribution strategies to ensure that our solution is accessible to all women who need it.
SelfCerve is a self-administered medical device that allows women in low-resource settings to screen for cervical cancer. Our technology eliminates needing an exam bed, stirrups, and even a trained practitioner for a diagnosis. Our mission with SelfCerve is to reach the last mile by normalizing cervical cancer screening globally. With the distribution of the SelfCerve device, we enable low-cost, quality screening with the ultimate goal of increased treatment of precancerous lesions.
WakeUp Pelvic is a digital health start-up that supports women in achieving pelvic physiotherapy goals. We offer a personalized approach to pelvic rehabilitation and empower women to take an active role in their treatment.
Data-driven, personalized, high-risk pregnancy care through an app promoting lifestyle changes. Adira health empowers pregnant women diagnosed with high blood pressure, gestational hypertension, and pre-eclampsia to gain awareness of their condition, signs, and symptoms improving birth experience and healthspan. Our health data and wellbeing counseling combined with care coordination enables better pregnancy outcomes for mom and baby.
Tech4Eva and the entire team was eagerly on the look-out for opportunities helpful to Adira Health and the entire cohort. The fine-tuned program and mentoring was instrumental in getting us further off the ground. I enjoyed the greater community and network of startups, partners, like-minded and experts in healthcare for women. If you look for a program and a cohort that puts start-ups first – then Tech4Eva is perfect for you!
CareMother Baby Beat is a portable, wireless, smartphone based, non-stress test (NST) device with AI capability, that can be used by mothers for self-monitoring of fetal health at home, with results shared with their doctor online for advice.
Intignus Biotech is developing simple and accessible solutions in the area of maternal and child health care. We aim to better clinical, operational, and economic outcomes by using point-of-care tests that allow on-the-spot decision-making for clinicians. Our first product addresses the unmet need for early screening of preeclampsia. This pregnancy-related disorder can strike quickly, potentially causing severe and immediate complications unless the pregnancy is induced. We have developed an affordable and easy-to-use screening test for all pregnant women which can predict preeclampsia development in the upcoming weeks of gestation.
It provided a great opportunity for peer learning from other founders and I also really valued having a Mentor who has experience building a start-up in SSA, being available to brainstorm some of the challenges of entrepreneurship.
Hale is a platform providing women with chronic pelvic pain with personalized mental health, to improve their quality of life.
The program also allows us to connect with potential partners, collaborators, distributors, and market access consultants. I'm also looking forward to making connections with global FemTech companies.
Egal’s Pads on a Roll help women manage their periods safely, privately, hygienically and with dignity. Pads on a Roll look like toilet paper, are individually wrapped, and are installed next to toilet paper so the products are available when and where they are needed. Typically period pads or tampons, if they are even stocked, are located in separate vending machines by the sink -- not where you want to find them, and often too late to help.
Egal means equal…all bodily functions should be treated equally.
Tech4Eva has been great. The mentors are especially helpful. The cohort is inspiring us, and you really get to know what everyone is going through more than other accelerators I have been involved with. Additionally, the special sessions have super useful specialists that I have learned a lot from. Since we have started Tech4 Eva, we have gotten a lot more global interest.
Beyond Genomix is a clinical stage MedTech developing next generation technologies for ncDNA analysis. With a focus on reproductive health, we have developed the only infertility test, capable of diagnosing every woman including those with an idiopathic condition, from the comfort of their home.
Tech4Eva creates a microcosm for budding FemHealth start-ups to share and grow in a special and focused community
We boost In Vitro Fertilisation success, helping doctors in decision-making by detecting the right timing for embryo transfer. We measure uterine readiness for embryo transfer on the same day of the transfer without interfering with the patient's journey and preserving endometrial tissue integrity.
$2 million fundraised in 2023
Tech4Eva was an eye opener and acted as a true accelerator of our mindset and the overall company evolution process. Monthly updating with a dedicated mentor has been fundamental in our journey. When peers are so close to you in their profile and needs, this is even a much better experience. I have found a community with a drive for cooperation and partnering. We are very grateful to the program and the organizers for the opportunity. We encourage young start-ups in Femtech to apply for the next cohort.
With our AI-driven technologies we increase chances for people to become parents. We provide greater accuracy in the diagnostic and treatment process, reducing the time and cost associated with fertility treatments and leading to better outcomes for our customers. Our flagship solutions are EMBRYOAID for automatic embryo ranking and FOLLISCAN - a 10-second ai-powered follicular ultrasound monitoring. Founder-led and with most PhDs, we have 50 experienced AI specialists.
Seed funding round closed in 2023 with an impressive $2M secured from Tangent Line Ventures and Peleton.
Participating in the Tech4Eva program was a huge support for MIM Fertility. The support and good energy we received during the program from the organizers and other participants were absolutely of great value to us.
LoOoP by Neuraura: Restoring Women’s Reproductive and Metabolic Health with a Wearable Bioelectronic Device. Neuraura is bringing to market the first effective, widely accessible treatment for PCOS as an over-the-counter, affordable device that augments the body's natural processes rather than just masking the symptoms.
Tech4Eva brings together some of the most promising start-ups in women’s health to provide peer support, industry-specific insights and world-class connections to potential customers, partners, and investors. In a few short months, I have built an ecosystem of committed, knowledgeable and accomplished experts in women’s health spanning the globe. I feel completely blessed to have this powerful group of supporters to call upon and ask for support, expertise, and connections. Given the headwinds that still exist in this field, this network is invaluable, and I would encourage anyone entering this industry to invest in that network early to test your ideas and learn from other’s successes and missteps.
Ru Medical is creating innovative technologies to transform menopausal care. Unpause is our holistic digital platform where menopausal women can log and track their symptoms and treatments to understand their journey better. The platform also connects to novel non-invasive technologies to relieve specific symptoms of menopause. Coolzen, our premier smart wearable, provides relief from hot flashes using the body’s natural cooling mechanism to bring instant relief to the user.
The workshops and mentors of Tech4Eva have been invaluable in bringing critical advice in jumping hurdles the start-up world presents. The coaches have been instrumental in connecting us with the right people to help our business grow.
Research confirms that mental health is metabolic health. HEALTHY-LONGER has developed and validated the first neuro-metabolic assessment and neuro-nutritional treatment addressing the root cause of mental health vulnerability and disorders – neuro-nutrient deficiencies. The technology is intended to be the first metabolic neuro-biomarker based diagnostic tool in mental health.
Being in the Tech4Eva program helped in building connections with the FemTech world and Tech4Eva's partners and validate our go-to-market strategy and closing our seed round.
Palpa is a unique product to train breast self-examination in the shower. It is a breast-shaped device that teaches women what an abnormality feels like and how to detect a tumor in their breasts to improve early detection of breast cancer during their shower routine.
I believe that Tech4Eva facilitates access to invaluable advisors and potential clients, allowing founders to gain valuable insights from the consumer sector and draw significant conclusions from those experiences.
Founded in 2004, Predilife, a pioneer of predictive medicine in France, designs and markets predictive tests, giving everyone the chance to find out their own risk of developing serious diseases. It combines proven medical techniques with Artificial Intelligence and Big Data.
Predictive medicine involves anticipating an individual’s future so that action can be taken in time thanks to personalised prevention, either by reducing risk, or by identifying the disease as early as possible. Serious conditions, such as cancer and heart attacks, can now be prevented better.
Partnership with Groupe Mutuel and a $2 million fundraise in 2023
Thanks to the various support services offered by Tech4Eva, our aim is to structure our international offering. The knowledge we have acquired about the various markets, international trade fairs and the quality of the network made available by Tech4Eva will enable us to arrive better prepared and more quickly on our various target market.
SelfCerve is a self-administered medical device that allows women in low-resource settings to screen for cervical cancer. Our technology eliminates needing an exam bed, stirrups, and even a trained practitioner for a diagnosis. Our mission with SelfCerve is to reach the last mile by normalizing cervical cancer screening globally. With the distribution of the SelfCerve device, we enable low-cost, quality screening with the ultimate goal of increased treatment of precancerous lesions.
NuroKorFemtech is developing new technology that can deploy personalized treatments that meet the needs of each individual and their experience of painful conditions affecting female reproductive health. Our team is bringing together expertise in bioelectronics, data science, and AI/ML to create the world’s first adaptive app-driven technology for menstrual health. We are on a real mission to revolutionize women's healthcare with the smartest therapeutic wearable. Period.
Samphire Neuroscience is a women's health company that builds neurotechnology-based solutions for neglected women's health needs. Its first medical device, the Samphire Hairband, will be available in early 2024 and is a wearable, non-invasive device that can address premenstrual low mood, anxiety, and menstrual pain complaints in women of reproductive age with diagnoses of PMS, PMDD, and dysmenorrhea from a home setting, drastically improving the standard of care and reducing the time to treatment for most women with these conditions
We are excited about the opportunity to collaborate with Tech4Eva's brilliant mentors and to learn from peers about creating effective solutions for women in the 21st century. In particular, we hope to gain early exposure to diverse distribution strategies to ensure that our solution is accessible to all women who need it.
WakeUp Pelvic is a digital health start-up that supports women in achieving pelvic physiotherapy goals. We offer a personalized approach to pelvic rehabilitation and empower women to take an active role in their treatment.